SOUTH SAN FRANCISCO, Calif., Nov. 26, 2019 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (GBT) today announced that it will present at the following investor conferences in December 2019:
- Evercore ISI 2nd Annual HealthCONx Conference in Boston on Tuesday, December 3, 2019 at 1:15 p.m. Eastern Time (ET); and
- 31st Annual Piper Jaffray Healthcare Conference in New York City on Wednesday, December 4, 2019 at 11:00 a.m. ET.
GBT is a biopharmaceutical company determined to discover, develop and deliver innovative treatments that provide hope to underserved patient communities. The company has one FDA-approved therapy for sickle cell disease and one investigational therapy in development for the disease. To learn more, please visit www.gbt.com and follow the company on Twitter @GBT_news.